Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (3)
  • 2024 (3)
  • 2023 (2)
  • 2022 (6)
  • 2021 (3)
  • 2018 (1)

Subject

  • Drug Trafficking (251)
  • Arrests/Convictions - Major (82)
  • Guilty Plea (65)
  • OCDETF/Task Force (55)
  • Guns/Weapons (31)
  • Synthetic drugs (27)
  • Money Laundering (17)
  • Pharmaceuticals/Pharmacists/Physicians (16)
  • Fake Pills (15)
  • Overdose (12)
  • Take Back Day (12)
  • Seizures (Drugs/Property) (10)
  • Diversion Division (9)
  • Outreach/Drug Prevention (7)
  • Fentanyl Awareness (6)
  • Major Law Enforcement Operation (6)
  • HIDTA (5)
  • Extraditions (4)
  • One Pill Can Kill (4)
  • Asset Forfeiture (3)
  • Task Forces/Task Force Officers (3)
  • Dark Web- Internet Trafficking (2)
  • Intelligence Division - Intelligence Products (1)
  • Intergovernmental Affairs (1)
  • International/Foreign Operations (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Prescription Drugs (18)

Drug Name

  • Opioids (5)
  • Oxycodone (4)
  • Amphetamines (3)
  • Hydromorphone (2)
  • Benzodiazepines (1)
  • Synthetic Opioids (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (34)
  • New England (24)
  • Seattle (23)
  • Sede (21)
  • Atlanta (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (13)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
  • Miami (18)
Clear All Results
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

Julio 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
Julio 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

Julio 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
Julio 27, 2022
PRESS RELEASE

DEA Holds 22nd National Prescription Drug Take Back Day to prevent addiction and reduce overdose deaths

Abril 19, 2022
MIAMI – The Drug Enforcement Administration will host its 22nd National Prescription Drug Take Back Day on Saturday, April 30 from 10 a.m. to 2 p.m. This bi-annual event offers free, anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. “Disposing of unneeded medications can help...
Abril 19, 2022
PRESS RELEASE

Pain Clinic Doctor and Staff Member Charged with Unlawful Distribution of Opioids

Enero 06, 2022
TAMPA, Fla. – United States Attorney Roger B. Handberg announced the return of an indictment charging Dr. Qing McGaha (55, Tampa) with conspiracy to commit unlawful distribution of controlled substances and unlawful distribution of controlled substances for no legitimate medical purpose and outside the usual course of professional practice, as...
Enero 06, 2022
PRESS RELEASE

Naples Doctor Who Operated a Pill Mill Sentenced to Three Years in Federal Prison

Diciembre 06, 2021
FORT MYERS, Fla. – U.S. District Judge Sheri Polster Chappell today sentenced Gerald Michael Abraham, 76, of Naples, Florida. to three years in federal prison for dispensing controlled substances (oxycodone and amphetamine) for no legitimate medical purpose. The court also ordered Abraham to forfeit the following items to the United...
Diciembre 06, 2021
PRESS RELEASE

Florida Man Pleads Guilty to Unlawfully Distributing Opioids at His Pain Management Clinic

Noviembre 10, 2021
MIAMI – A Florida man pleaded guilty yesterday to unlawfully distributing opioids at his pain management clinic in Miami, Florida. According to court documents, Habib Geagea Palacios, 40, of Miami, owned a cash-only pain management clinic in Miami, Florida named General Care Center, Inc. At General Care Center, Palacios paid...
Noviembre 10, 2021
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

Noviembre 01, 2021
MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
Noviembre 01, 2021
PRESS RELEASE

Tampa doctor pleads guilty to distributing opioids outside DEA registration

Julio 13, 2018
TAMPA, Fla. – Jeffrey John Abraham (52, formerly of Tampa) has pleaded guilty to distributing controlled substances not specified in his Drug Enforcement Administration (DEA) registration. He faces a maximum penalty of four years’ imprisonment and a fine of up to $250,000. His sentencing date has not yet been set...
Julio 13, 2018
Showing 11 - 18 of 18 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Current page 2
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster